emoxypine succinate has been researched along with Brain Ischemia in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (5.13) | 29.6817 |
| 2010's | 26 (66.67) | 24.3611 |
| 2020's | 11 (28.21) | 2.80 |
| Authors | Studies |
|---|---|
| Nikolaev, YA; Pervuninskaya, MA; Shchepankevich, LA; Shchepankevich, MS; Taneeva, EV | 1 |
| Chukanova, EI; Fedin, AI; Madzhidova, EN; Ostroumova, OD; Shchepankevich, LA; Tanashyan, MM; Zakharov, VV | 1 |
| Kantemirova, FS; Karpov, SM; Morozova, MY; Muravyov, KA; Vyshlova, IA | 1 |
| Pugacheva, EL | 1 |
| Bagmanyan, SJ; Chukanova, AS; Chukanova, EI; Gulieva, MS; Kotel'nikova, SO; Kraineva, VA; Val'dman, EA; Voronina, TA; Zolotov, NN | 1 |
| Fedin, AI; Mkhitaryan, EA; Tkacheva, ON; Zakharov, VV | 1 |
| Chukanova, AS; Chukanova, EI | 1 |
| Skachilova, SY; Voronina, TA; Yasnetsov, VV | 1 |
| Kutashov, VA; Ulyanova, OV | 1 |
| Androfagina, OV; Strelnikova, IA; Svetkina, AA | 1 |
| Abramenko, YV | 1 |
| Mkhitaryan, EA; Ostroumova, OD; Ostroumova, TM; Stakhovskaya, LV; Tkacheva, ON | 1 |
| Domashenko, MA; Konstantinov, VI; Loskutnikov, MA; Proskuryakova, OS; Shchukina, EP; Trushina, IA; Vakin, TM | 1 |
| Kataeva, NG; Svetlik, MV; Zamoshchina, TA | 1 |
| Gudasheva, TA; Povarnina, PY; Seredenin, SB; Volkova, AA | 1 |
| Aliev, OI; Plotnikov, DM; Stegmeier, MN | 1 |
| Novikova, LB; Sarafutdinova, LR; Sharapova, KM | 1 |
| Barulin, AE; Konovalova, OV; Kurushina, OV | 1 |
| Kochetov, AG; Lyang, OV | 1 |
| Duma, SN | 1 |
| Bezgina, EV; Poverennova, IE; Zolotovskaia, IA | 1 |
| Chel'naia, NA; Iasnetsov, VV; Ivanov, IuV; Karsanova, SK; Motin, VG; Ozerov, AA | 1 |
| Faĭzullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, II; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Chukanova, AS; Chukanova, EI; Mamayeva, KI | 1 |
| Anisimova, VA; Kosolapov, VA; Sorotskii, DV; Spasov, AA | 1 |
| Berezhnaya, SV; Yakupov, EZ | 1 |
| Alikhanyan, CB; Bagdasaryan, MG; Bagdasaryan, NA; Kukhtarova, AM; Meliksetyan, VS; Mirzoyan, NR | 1 |
| Golovkin, VI; Popova, LO; Shapovalov, AS; Svetlikov, AV | 1 |
| Konoplya, AI; Laskov, VB; Shul'ginova, AA | 1 |
| Antipenko, EA; Derugina, AV; Gustov, AV | 1 |
| Berezhnaya, SV; Yakupov, EZ; Zaharov, YA | 1 |
| Ivanov, YV; Karsanova, SK; Skachilova, SY; Tsublova, EG; Yasnetsov, VV | 1 |
| Bukina, SJ; Inchina, VI | 1 |
| Chugunov, AV; Kamchatnov, PR; Mikhaĭlova, NA | 1 |
| Avdiunina, NI; Gan'shina, TS; Gnezdilova, AV; Gorbunov, AA; Kurdiumov, IN; Mirzoian, RS; Piatin, BM | 1 |
| Gan'shina, TS; Gorbunov, AA; Mirzoian, RS; Turilova, AI | 1 |
| Abramenko, IuV | 1 |
| Antipenko, EA | 1 |
| Fedin, AI; Rumiantseva, SA; Sokhova, ON | 1 |
2 review(s) available for emoxypine succinate and Brain Ischemia
| Article | Year |
|---|---|
[The use of mexidol in chronic cerebral ischemia].
Topics: Antioxidants; Brain Ischemia; Humans; Oxidative Stress; Picolines | 2013 |
[Correction of free-radical oxidation as a pathogenetic approach to the treatment of acute ischemic stroke].
Topics: Antioxidants; Brain Ischemia; Free Radical Scavengers; Humans; Oxidation-Reduction; Picolines; Stroke; Treatment Outcome | 2009 |
14 trial(s) available for emoxypine succinate and Brain Ischemia
| Article | Year |
|---|---|
[Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
Topics: Asthenia; Brain Ischemia; Double-Blind Method; Humans; Picolines; Treatment Outcome | 2021 |
[Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke].
Topics: Brain Ischemia; Female; Humans; Male; Pharmaceutical Preparations; Picolines; Stroke | 2022 |
[Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients w
Topics: Adult; Asthenia; Brain Ischemia; Cognitive Dysfunction; Female; Humans; Infant; Male; Middle Aged; Quality of Life | 2022 |
[Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
Topics: Antioxidants; Brain; Brain Ischemia; Humans; Neuroimaging; Picolines | 2019 |
[The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Topics: Administration, Oral; Antioxidants; Atherosclerosis; Brain Ischemia; Cognition; Emotions; Humans; Hypertension; Injections, Intravenous; Picolines | 2019 |
[The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
Topics: Brain Ischemia; Carotid Artery Diseases; Humans; Picolines; Stroke; Treatment Outcome | 2020 |
[Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)]
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Male; Middle Aged; Picolines; Quality of Life; Stroke | 2020 |
[The use of mexidol in acute period of ischemic stroke].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Hemostasis; Humans; Male; Middle Aged; Picolines; Stroke | 2013 |
[Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Topics: Aged; Antioxidants; Asthenia; Brain Ischemia; Chronic Disease; Cognition Disorders; Female; Humans; Lipoproteins, LDL; Middle Aged; Picolines; Treatment Outcome | 2013 |
[Diagnosis and treatment of asthenic syndrome in elderly people after acute respiratory viral infection].
Topics: Acute Disease; Aged; Antioxidants; Asthenia; Brain Ischemia; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Picolines; Psychotropic Drugs; Respiratory Tract Infections; Syndrome | 2014 |
[The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Brain Ischemia; Chronic Disease; Dose-Response Relationship, Drug; Emotions; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroimaging; Picolines; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2015 |
[The efficacy of mexidol in carotid endarterectomy procedure in patients with cerebral atherosclerotic stenosis].
Topics: Aged; Antioxidants; Brain; Brain Ischemia; Carotid Stenosis; Cerebrovascular Circulation; Combined Modality Therapy; Endarterectomy, Carotid; Female; Humans; Male; Middle Aged; Operative Time; Oximetry; Perioperative Period; Picolines | 2016 |
[The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Topics: Aged; Antioxidants; Brain; Brain Ischemia; Cerebrovascular Circulation; Female; Humans; Injections, Intramuscular; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Picolines; Superoxide Dismutase; Treatment Outcome | 2011 |
[Adaptogenic effects of mexidol in chronic cerebral ischemia].
Topics: Adaptation, Physiological; Adult; Antioxidants; Brain Ischemia; Chronic Disease; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Picolines | 2012 |
23 other study(ies) available for emoxypine succinate and Brain Ischemia
| Article | Year |
|---|---|
[The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
Topics: Aged; Brain Ischemia; Humans; Neuroimaging; Picolines; Quality of Life | 2021 |
[Efficacy of Mexidol in patients with type 2 diabetes mellitus with neurological complications].
Topics: Antioxidants; Brain Ischemia; Diabetes Mellitus, Type 2; Humans; Picolines; Quality of Life | 2022 |
Topics: Animals; Apoptosis; Biomarkers; Brain Ischemia; Brain-Derived Neurotrophic Factor; Hematoma; Hemorrhagic Stroke; Humans; Ischemic Stroke; Male; Oxidative Stress; Phosphopyruvate Hydratase; Picolines; Prognosis; Quality of Life; Rats; Stroke; Tumor Suppressor Protein p53 | 2022 |
Neuroprotective and Antiamnestic Effects of a New Drug Emopag in Rats.
Topics: Amnesia; Animals; Brain Ischemia; Disease Models, Animal; Glutamates; Male; Memory; Neuroprotective Agents; Picolines; Pyridines; Rats; Thiadiazoles | 2019 |
[Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Topics: Brain Ischemia; Chronic Disease; Humans; Neuroimaging; Picolines; Treatment Outcome | 2020 |
[The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
Topics: Brain Ischemia; Humans; Picolines; Quality of Life; Stroke; Treatment Outcome | 2020 |
[Effectiveness and safety of mexidol forte 250 in the sequential therapy in patients with chronic ischemia].
Topics: Brain Ischemia; Female; Humans; Ischemia; Male; Picolines; Treatment Outcome | 2020 |
Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Injections, Intraperitoneal; Middle Cerebral Artery; Molecular Mimicry; Neuroprotective Agents; Neurotrophin 3; Picolines; Rats; Rats, Wistar; Stroke | 2017 |
[Evaluation of blood rheology by patients with acute ischemic stroke with Mexidol administration].
Topics: Blood Viscosity; Brain Ischemia; Erythrocyte Aggregation; Erythrocyte Deformability; Humans; Picolines; Platelet Aggregation Inhibitors; Regional Blood Flow; Rheology; Stroke | 2019 |
[Correction of psychoemotional and autonomic dysfunction in patients with ischemic stroke].
Topics: Aged; Antioxidants; Anxiety; Autonomic Nervous System Diseases; Brain Ischemia; Female; Humans; Male; Nootropic Agents; Picolines; Stroke | 2013 |
[Study of some pharmacological properties of a new adenine derivative].
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Adenine; Animals; Brain Ischemia; CA1 Region, Hippocampal; Dizocilpine Maleate; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Male; Neuroprotective Agents; Picolines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Tissue Culture Techniques | 2014 |
[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Topics: Acute Disease; Animals; Brain Ischemia; Disease Models, Animal; Female; Male; Meglumine; Mice; Picolines; Pyridines; Succinates; Thioctic Acid | 2014 |
Effect of Pyrrolobenzimidazole Derivative RU-792 on Experimental Brain Ischemia.
Topics: Animals; Benzimidazoles; Brain Ischemia; Glutathione Peroxidase; Lipid Peroxidation; Male; Oxidation-Reduction; Picolines; Pyrroles; Rats | 2015 |
[The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
Topics: Aged; Antioxidants; Bencyclane; Brain Ischemia; Chronic Disease; Drug Therapy, Combination; Escin; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Picolines; Treatment Outcome | 2015 |
[THE INFLUENCE OF MEXIDOL AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE ON LIPOFUSCINE CONTENT IN RAT BRAIN UNDER LOCAL PERMANENT ISCHEMIA CONDITIONS].
Topics: Animals; Antioxidants; Brain; Brain Chemistry; Brain Ischemia; Lipofuscin; Male; Picolines; Pyridines; Rats | 2015 |
[Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
Topics: Adult; Amino Acids; Antioxidants; Brain Ischemia; C-Reactive Protein; Chronic Disease; Complement C1 Inhibitor Protein; Complement Factor H; Complement System Proteins; Cytokines; Drug Therapy, Combination; Female; Heme; Humans; Hydrogen Peroxide; Immunoglobulins; Male; Malondialdehyde; Middle Aged; Nootropic Agents; Picolines; Piracetam | 2015 |
[The system stress-limiting action of mexidol in chronic cerebral ischemia].
Topics: Antioxidants; Brain Ischemia; Female; Humans; Male; Middle Aged; Picolines; Piracetam | 2016 |
[The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
Topics: Aged; Amino Acids; Antioxidants; Brain Ischemia; Drug Therapy, Combination; Elements; Female; Hair; Humans; Male; Middle Aged; Neuroprotective Agents; Picolines; Treatment Outcome | 2016 |
[STUDYING SOME PHARMACOLOGICAL EFFECTS OF NEW 3-HYDROXYPYRIDINE DERIVATIVE].
Topics: Adamantane; Amnesia; Animals; Animals, Outbred Strains; Anticonvulsants; Benzimidazoles; Brain Ischemia; Disease Models, Animal; Exercise Test; Gluconeogenesis; Male; Mice; Neuroprotective Agents; Nootropic Agents; Physical Conditioning, Animal; Picolines; Piracetam; Rats; Swimming; Tryptophan | 2016 |
Neuroprotective activity of mexidole and 3-hydroxypyridine acetylcysteinate against the background of cerebral ischemia in the complex of experimental diabetes mellitus and exogenous hypercholesterolemia.
Topics: Acetylcysteine; Animals; Brain Ischemia; Diabetes Mellitus, Experimental; Female; Hypercholesterolemia; Male; Neuroprotective Agents; Picolines; Rats; Treatment Outcome | 2008 |
[Influence of 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate on cerebral blood perfusion in rats under experimental pathology conditions].
Topics: Animals; Antioxidants; Aza Compounds; Brain; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery, Internal; Cerebrovascular Circulation; Disease Models, Animal; Drug Combinations; Male; Neuroprotective Agents; Picolines; Piperazines; Rats; Serotonin Antagonists; Serotonin Receptor Agonists | 2011 |
[Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Topics: Animals; Antioxidants; Aza Compounds; Brain; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery, Internal; Cerebrovascular Circulation; Disease Models, Animal; Drug Combinations; Male; Picolines; Piperazines; Rats; Serotonin Antagonists; Serotonin Receptor Agonists; Vasodilator Agents | 2011 |
[The antioxidant treatment of cerebral ischemic lesions].
Topics: Antioxidants; Brain Ischemia; Humans; Picolines | 2011 |